Briefing: USPTO “Drug Patent and Exclusivity Report”
On Monday, September 9, the Council for Innovation Promotion hosted an important briefing on the U.S. Patent and Trademark Office’s recently released Drug Patent and Exclusivity Study. The study, requested by Senator Thom Tillis (R-NC), investigated the relationship between patents and market exclusivity for a sample of FDA-approved drugs, finding that patent expiration alone did […]
Briefing: USPTO “Drug Patent and Exclusivity Report” Read More »